Sedation with Sevoflurane versus Propofol in COVID-19 Patients with Acute Respiratory Distress Syndrome: Results from a Randomized Clinical Trial

Background: Acute respiratory distress syndrome (ARDS) related to COVID-19 (coronavirus disease 2019) led to intensive care units (ICUs) collapse. Amalgams of sedative agents (including volatile anesthetics) were used due to the clinical shortage of intravenous drugs (mainly propofol and midazolam)....

Descripción completa

Detalles Bibliográficos
Autores principales: Martínez-Castro, Sara, Monleón, Berta, Puig, Jaume, Ferrer Gomez, Carolina, Quesada, Marta, Pestaña, David, Balvis, Alberto, Maseda, Emilio, de la Rica, Alejandro Suárez, Feijoo, Ana Monero, Badenes, Rafael
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10305722/
https://www.ncbi.nlm.nih.gov/pubmed/37373914
http://dx.doi.org/10.3390/jpm13060925

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10305722/
https://www.ncbi.nlm.nih.gov/pubmed/37373914
http://dx.doi.org/10.3390/jpm13060925

Ejemplares similares